Twice weekly intravenous injections of tumor-bearing mice with 0.1 mg 4T-Trap selectively inhibited Th cell TGF-β signaling in tumor-draining lymph nodes, leading to an IL-4-dependent tumor vasculature reorganization and cancer cell death in four weeks. Here, TGFB1 is linked to cancer.